By increasing NAD levels and activating the SIRT1 pathway, NNMTi inhibits the activation of inflammatory signaling pathways (such as the NFB pathway), thereby reducing macrophage infiltration and inflammatory factor release
The practical takeaway: AOD-9604 has a clean safety profile in trials but a failed Phase 2b efficacy endpoint
Not for Human Consumption, For Research Use Only
Secondary osteoporosis: obesity, diabetes, long-term sedentary, hormone drugs, excessive fat reduction, etc., interfere with calcium and phosphorus metabolism, inhibit osteogenesis, promote osteoclasis, and cause bone loss
We serve patients from West Moore OK, Edmond OK, Tecumseh OK, Yukon OK, I-240 & Sooner RD OK, Norman (HealthPlex) OK, Norman (24th) OK, Bethany OK, and surrounding areas